Search research articles
Contact Us
Filters
Showing results (341-350 of 455) with videos related to
Page
of 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2016
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele, Pieter Busschaert, Dominiek Smeets, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)
Philipp Harter, David Gershenson, Catherine Lhomme, et al.
Molecular Cancer
|
September 18, 2012
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium
Stefanie Aust, Anna Bachmayr-Heyda, Petra Pateisky, et al.
Journal of Ovarian Research
|
July 2, 2013
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
Fabian Trillsch, Linn Woelber, Christine Eulenburg, et al.
Current Issues in Molecular Biology
|
November 24, 2023
Galectin-10 Expression in Placentas of Women with Gestational Diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Oncotarget
|
January 2, 2018
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
Eva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, et al.
Gynecologic Oncology
|
January 6, 2016
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
Günter Emons, Christian Kurzeder, Barbara Schmalfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2014
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
Sven Mahner, Werner Meier, Andreas du Bois, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
Elena Sultova, C Benedikt Westphalen, Andreas Jung, et al.
Biomedicines
|
February 25, 2022
<i>FAM111A</i> Is a Novel Molecular Marker for Oocyte Aging
Huixia Yang, Thomas Kolben, Mirjana Kessler, et al.
Page
of 46
Search research articles
Search
Showing results (341-350 of 455) with videos related to
Sort By:
Page
of 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2016
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele, Pieter Busschaert, Dominiek Smeets, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)
Philipp Harter, David Gershenson, Catherine Lhomme, et al.
Molecular Cancer
|
September 18, 2012
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium
Stefanie Aust, Anna Bachmayr-Heyda, Petra Pateisky, et al.
Journal of Ovarian Research
|
July 2, 2013
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
Fabian Trillsch, Linn Woelber, Christine Eulenburg, et al.
Current Issues in Molecular Biology
|
November 24, 2023
Galectin-10 Expression in Placentas of Women with Gestational Diabetes
Christina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Oncotarget
|
January 2, 2018
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
Eva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, et al.
Gynecologic Oncology
|
January 6, 2016
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
Günter Emons, Christian Kurzeder, Barbara Schmalfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2014
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
Sven Mahner, Werner Meier, Andreas du Bois, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
Elena Sultova, C Benedikt Westphalen, Andreas Jung, et al.
Biomedicines
|
February 25, 2022
<i>FAM111A</i> Is a Novel Molecular Marker for Oocyte Aging
Huixia Yang, Thomas Kolben, Mirjana Kessler, et al.
Page
of 46